The immunogenicity of GSK’s recombinant hepatitis B vaccine in children: a systematic review of 30 years of experience
Introduction: The World Health Organization recommends hepatitis B virus (HBV) vaccines to be included in national immunization schedules everywhere, and has adopted the strategic goal of halting viral hepatitis as a major public health threat by 2030, under which vaccination plays a major role. Eng...
Main Authors: | Caroline van den Ende, Cinzia Marano, Ayla van Ahee, Eveline M. Bunge, Laurence De Moerlooze |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2017-08-01
|
Series: | Expert Review of Vaccines |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/14760584.2017.1338569 |
Similar Items
-
The immunogenicity and safety of GSK’s recombinant hepatitis B vaccine in adults: a systematic review of 30 years of experience
by: Caroline Van Den Ende, et al.
Published: (2017-08-01) -
IMMUNOGENICITY OF THE THIRD GENERATION HEPATITIS B VACCINE (pre-S1/pre-S2/S)
by: E. V. Esaulenko, et al.
Published: (2018-05-01) -
Immunogenicity persistence in children of hepatitis A vaccines Healive® and Havrix®: 11 years follow-up and long-term prediction
by: Yongji Wang, et al.
Published: (2020-10-01) -
Influences of obesity on the immunogenicity of Hepatitis B vaccine
by: Fang Liu, et al.
Published: (2017-05-01) -
The First Assessments of Pediatric HBV Immunization Coverage in Mauritania and Persistence of Antibody Titers Post Infant Immunizations
by: Hala El Hachimi, et al.
Published: (2023-03-01)